BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3704313)

  • 1. Effects of antiarrhythmic agents on isoproterenol-induced ventricular fibrillation in heavy rats: a possible model of sudden cardiac death.
    Johnson GL; Ehrreich SJ; el-Hage AN; Balazs T
    Res Commun Chem Pathol Pharmacol; 1986 Mar; 51(3):351-64. PubMed ID: 3704313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Method for the production of severe ventricular dysrhythmias in small laboratory animals.
    Guideri G; Barletta M; Chau R; Green M; Lehr D
    Recent Adv Stud Cardiac Struct Metab; 1975; 10():661-79. PubMed ID: 1209009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental evaluation of antiarrhythmic drugs in the guinea pig.
    Giudicelli JF; Witchitz S; Larno S; Boissier JR
    Biomedicine; 1973 Jul; 19(7):308-13. PubMed ID: 4783987
    [No Abstract]   [Full Text] [Related]  

  • 4. Suppression of refractory recurrent ventricular tachycardia by transvenous rapid cardiac pacing and antiarrhythmic drugs. Report of seven cases.
    Friedberg CK; Lyon LJ; Donoso E
    Am Heart J; 1970 Jan; 79(1):44-50. PubMed ID: 5410281
    [No Abstract]   [Full Text] [Related]  

  • 5. The potential mechanisms of reduced incidence of ventricular fibrillation as the presenting rhythm in sudden cardiac arrest.
    Wang H; Tang W; Ristagno G; Li Y; Sun S; Wang T; Weil MH
    Crit Care Med; 2009 Jan; 37(1):26-31. PubMed ID: 19050623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The possible role of antiarrhythmic drugs in the prevention of sudden death.
    McAllister RG
    Heart Lung; 1973; 2(6):857-61. PubMed ID: 4490729
    [No Abstract]   [Full Text] [Related]  

  • 7. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitiative comparison of bretylium with other antifibrillatory drugs.
    Bacaner MB
    Am J Cardiol; 1968 Apr; 21(4):504-12. PubMed ID: 5650730
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of arrhythmia in general practice].
    Steinbach K
    Wien Med Wochenschr; 1975 Nov; 125(46):658-61. PubMed ID: 1229124
    [No Abstract]   [Full Text] [Related]  

  • 10. Differential effect of selected antiarrhythmic drugs on coronary artery ligation-induced ventricular arrhythmias on the right or left sides.
    Gautam CS; Sharma PL; Pandhi P
    Methods Find Exp Clin Pharmacol; 1995 Jun; 17(5):327-31. PubMed ID: 8830201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiarrhythmic drugs.
    Moses HW; Yu PN
    J Clin Pharmacol; 1980 Oct; 20(10):598-618. PubMed ID: 7002961
    [No Abstract]   [Full Text] [Related]  

  • 12. [Anti-arrhythmia agents].
    Kaufmann G
    Med Klin; 1974 May; 69(18):778-86. PubMed ID: 4134645
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevention of sudden coronary death by chronic antiarrhythmic therapy.
    Koch-Weser J
    Adv Cardiol; 1978; 25():206-28. PubMed ID: 360790
    [No Abstract]   [Full Text] [Related]  

  • 14. Fibrilation threshold curves and anti-arrhythmic drugs.
    Vanremoortere E; Wauters E
    Arch Int Pharmacodyn Ther; 1968 Dec; 176(2):476-9. PubMed ID: 5715418
    [No Abstract]   [Full Text] [Related]  

  • 15. Prophylactic uses of antiarrhythmic drugs in acute myocardial infarction.
    Chung EK
    Postgrad Med; 1973 Oct; 54(4):197-203. PubMed ID: 4729173
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antiarrhythmic properties of fubromegan on different models of experimental cardiac arrhythmia].
    Samvelian VM; L'vov MV
    Farmakol Toksikol; 1970; 33(3):309-13. PubMed ID: 4393833
    [No Abstract]   [Full Text] [Related]  

  • 17. Enhanced incidence of isoproterenol-induced ventricular fibrillation in the magnesium-deficient rat.
    Guideri G; Lehr D; Horowitz S
    J Am Coll Nutr; 1985; 4(2):139-55. PubMed ID: 4019937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of ventricular arrhythmias].
    Frohner K
    Wien Med Wochenschr; 1984 Oct; 134(19-20):448-57. PubMed ID: 6516421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Piperazine protects the rat heart against sudden cardiac death from barium chloride-induced ventricular fibrillation.
    Ghasi S
    Am J Ther; 2008; 15(2):119-25. PubMed ID: 18356631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current anti-arrhythmic treatments and drugs].
    Chiche P; Witchitz S; Naouri L; Philippe B
    Coeur Med Interne; 1973; 12(1):129-44. PubMed ID: 4146955
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.